Pablo A. Ballesteros
@pabloteros
MD, MSc. Medical Oncologist at Hospital 12 de Octubre.
Asturian in Madrid. Like ≠ endorsement.
ID: 301698128
19-05-2011 22:18:11
1,1K Tweet
254 Followers
375 Following
1/9 Glad to announce that the #CAPTURE study manuscript has been published today in Annals of Oncology Would you like to learn more about it? Just follow this #tweetorial thread 👇 annalsofoncology.org/article/S0923-…
An interesting retrospective analysis shedding light on the impact of corticosteroids in the outcomes of immunotherapy treatments. Nice work by the residents of Oncología Médica Hospital Ramón y Cajal, where I did my training. A pleasure to collaborate in this paper.
I'm thrilled to share our latest article in Annals of Oncology which we developed during my time in the MD Anderson Cancer Center It's been an honor to collaborate with these titans of oncology, mentors and friends, as Mohamed A Gouda Ignacio Garrido-Laguna and Jordi Rodon.
🎯🎯 Starting the IV Trending topics in GU Cancer!! #GUtrends25 excelent program!! Uromigos UroToday.com OncoAlert Hospital Universitario 12 de Octubre GU Cast | Urology podcast! GUARD Consortium Pablo A. Ballesteros Lola R.Nogueira Guillermo de Velasco Tom Powles Elena Castro
A Special Treat from #GUTrends25 🌴In SPANISH🇪🇸 Drs. Guillermo de Velasco , Cristina Suarez & Alfonso Gomez de Liaño discuss Future Trials in #KidneyCancer Courtesy of our friends the Uromigos 🚨 Ping: Hospital Universitario 12 de Octubre Pablo A. Ballesteros Lola R.Nogueira Guillermo de Velasco Tom Powles Elena Castro
Great time in Amsterdam for the IKCS Europe 2025 IKCC Kidney Cancer with the amazing Guillermo de Velasco Glad to share our latest lab results highlighting biomarkers of response to cabozantinib treatment Daniel Castellano
Zach Klaassen UroToday.com Josette Staufert Marmolejo Similar outcomes were reportes in our serie! (Hospital Universitario 12 de Octubre) by Dr Pablo Ballesteros remarking the value of 4 vs 6 cycles !! OncoAlert ESMO - Eur. Oncology #ESMO25
Ending the ESMO Congress 2025! Amazing days in Berlin with friends. A pleasure to present our work in the GU poster session with resistance signals to QT+IO treatment in urothelial carcinoma transcriptomics and consistent RWD in CPRCm treated with Ra223 Guillermo de Velasco Daniel Castellano